BIOMAT Database Logo BIOMAT Database Logo

Discovery of aminopyridine-containing spiro derivatives as EGFR mutations inhibitors. 2019

Lianbao Ye, and Tao Zhao, and Wenjun Du, and Anhu Li, and Wei Gao, and Jingrong Li, and Ling Wang, and Weiqiang Chen
a School of Pharmacy , Guangdong Pharmaceutical University , Guangzhou , China.

Neratinib is an oral pan HER inhibitor, that irreversibly inhibits EGFR and HER2 and was proven to be effective against multiple EGFR mutations. In previous study, we reported spiro [indoline-3, 4'-piperidine]-2-ones as anticancer agents. In this study, we designed aminopyridine-containing spiro [indoline-3,4'-piperidine] derivatives A1-A4 using Neratinib and spiro [indoline-3, 4'-piperidine]-2-one compound patented as lead structure, then replaced piperidine with cyclopropane to obtain B1-B7 and replaced indoline with benzmorpholine to get C1-C4 and D1-D2. We synthesized these compounds and evaluated their residual activities under 0.5 M drug concentration on EGFR and ERBB2. Most of compounds showed stronger inhibition on EGFR-wt and ERBB2, in which A1-A4 showed excellent inhibitory activity with inhibition percentage on EGFR-wt kinase of 7%, 6%, 19%, 27%, respectively and 9%, 5%, 12%, 34% on ERBB2 kinase compared with 2% and 6% of Neratinib.

UI MeSH Term Description Entries
D009154 Mutation Any detectable and heritable change in the genetic material that causes a change in the GENOTYPE and which is transmitted to daughter cells and to succeeding generations. Mutations
D004815 Epidermal Growth Factor A 6-kDa polypeptide growth factor initially discovered in mouse submaxillary glands. Human epidermal growth factor was originally isolated from urine based on its ability to inhibit gastric secretion and called urogastrone. Epidermal growth factor exerts a wide variety of biological effects including the promotion of proliferation and differentiation of mesenchymal and EPITHELIAL CELLS. It is synthesized as a transmembrane protein which can be cleaved to release a soluble active form. EGF,Epidermal Growth Factor-Urogastrone,Urogastrone,Human Urinary Gastric Inhibitor,beta-Urogastrone,Growth Factor, Epidermal,Growth Factor-Urogastrone, Epidermal,beta Urogastrone
D000631 Aminopyridines Pyridines substituted in any position with an amino group. May be hydrogenated but must retain at least one double bond. Aminopyridine
D013141 Spiro Compounds Cyclic compounds that include two rings which share a single atom (usually a carbon). The simplest example of this type of compound is Spiro[2.2]pentane, which looks like a bow tie. Compounds, Spiro
D055808 Drug Discovery The process of finding chemicals for potential therapeutic use. Drug Prospecting,Discovery, Drug,Prospecting, Drug
D062105 Molecular Docking Simulation A computer simulation technique that is used to model the interaction between two molecules. Typically the docking simulation measures the interactions of a small molecule or ligand with a part of a larger molecule such as a protein. Molecular Docking,Molecular Docking Simulations,Molecular Docking Analysis,Analysis, Molecular Docking,Docking Analysis, Molecular,Docking Simulation, Molecular,Docking, Molecular,Molecular Docking Analyses,Molecular Dockings,Simulation, Molecular Docking
D021241 Spectrometry, Mass, Electrospray Ionization A mass spectrometry technique used for analysis of nonvolatile compounds such as proteins and macromolecules. The technique involves preparing electrically charged droplets from analyte molecules dissolved in solvent. The electrically charged droplets enter a vacuum chamber where the solvent is evaporated. Evaporation of solvent reduces the droplet size, thereby increasing the coulombic repulsion within the droplet. As the charged droplets get smaller, the excess charge within them causes them to disintegrate and release analyte molecules. The volatilized analyte molecules are then analyzed by mass spectrometry. ESI Mass Spectrometry,Electrospray Ionization Mass Spectrometry,Mass Spectrometry, ESI,Spectrometry, ESI Mass
D066244 Proton Magnetic Resonance Spectroscopy Spectroscopy technique which measures changes in organic compounds by tracking the spectral energy of absorption of HYDROGEN atoms. 1H NMR,1H-MRS,1H-NMR

Related Publications

Lianbao Ye, and Tao Zhao, and Wenjun Du, and Anhu Li, and Wei Gao, and Jingrong Li, and Ling Wang, and Weiqiang Chen
Discovery of thiapyran-pyrimidine derivatives as potential EGFR inhibitors.
October 2020, Bioorganic & medicinal chemistry,
Lianbao Ye, and Tao Zhao, and Wenjun Du, and Anhu Li, and Wei Gao, and Jingrong Li, and Ling Wang, and Weiqiang Chen
Discovery and optimization of 2-aminopyridine derivatives as novel and selective JAK2 inhibitors.
April 2020, Bioorganic & medicinal chemistry letters,
Lianbao Ye, and Tao Zhao, and Wenjun Du, and Anhu Li, and Wei Gao, and Jingrong Li, and Ling Wang, and Weiqiang Chen
Discovery of a series of novel phenylpiperazine derivatives as EGFR TK inhibitors.
September 2015, Scientific reports,
Lianbao Ye, and Tao Zhao, and Wenjun Du, and Anhu Li, and Wei Gao, and Jingrong Li, and Ling Wang, and Weiqiang Chen
Discovery of Benzo[g]quinazolin benzenesulfonamide derivatives as dual EGFR/HER2 inhibitors.
December 2017, European journal of medicinal chemistry,
Lianbao Ye, and Tao Zhao, and Wenjun Du, and Anhu Li, and Wei Gao, and Jingrong Li, and Ling Wang, and Weiqiang Chen
Discovery of 4,6-pyrimidinediamine derivatives as novel dual EGFR/FGFR inhibitors aimed EGFR/FGFR1-positive NSCLC.
February 2020, European journal of medicinal chemistry,
Lianbao Ye, and Tao Zhao, and Wenjun Du, and Anhu Li, and Wei Gao, and Jingrong Li, and Ling Wang, and Weiqiang Chen
Rational design-aided discovery of novel 1,2,4-oxadiazole derivatives as potential EGFR inhibitors.
September 2021, Bioorganic chemistry,
Lianbao Ye, and Tao Zhao, and Wenjun Du, and Anhu Li, and Wei Gao, and Jingrong Li, and Ling Wang, and Weiqiang Chen
Discovery of novel quinazoline derivatives bearing semicarbazone moiety as potent EGFR kinase inhibitors.
January 2018, Computational and structural biotechnology journal,
Lianbao Ye, and Tao Zhao, and Wenjun Du, and Anhu Li, and Wei Gao, and Jingrong Li, and Ling Wang, and Weiqiang Chen
Chronicles of EGFR Tyrosine Kinase Inhibitors: Targeting EGFR C797S Containing Triple Mutations.
January 2022, Biomolecules & therapeutics,
Lianbao Ye, and Tao Zhao, and Wenjun Du, and Anhu Li, and Wei Gao, and Jingrong Li, and Ling Wang, and Weiqiang Chen
Discovery of 5-Phenoxy-2-aminopyridine Derivatives as Potent and Selective Irreversible Inhibitors of Bruton's Tyrosine Kinase.
October 2020, International journal of molecular sciences,
Lianbao Ye, and Tao Zhao, and Wenjun Du, and Anhu Li, and Wei Gao, and Jingrong Li, and Ling Wang, and Weiqiang Chen
Discovery of benzamide derivatives containing urea moiety as soluble epoxide hydrolase inhibitors.
October 2022, Bioorganic chemistry,
Copied contents to your clipboard!